Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,041 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,668 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06406322 | Pelvic Floor Dysfunction and Aerobic Training in Gynecological Cancer | unknown | N/A | 40 | Atılım UniversityOTHER | 0 | May 9, 2024 | clinicaltrials |
| NCT00892866 | CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells | unknown | N/A | 877 | GOG FoundationNETWORK | 3 | May 3, 2024 | clinicaltrials |
| NCT01649089 |
| Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer |
| unknown |
| N/A |
| 224 |
| GOG FoundationNETWORK |
| 3 |
| May 3, 2024 |
| clinicaltrials |
| NCT06081686 | Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 32 | Sinotau Pharmaceutical GroupINDUSTRY | 1 | May 3, 2024 | clinicaltrials |
| NCT02296307 | DOvEE - Diagnosing Ovarian & Endometrial Cancer Early(DOvEE) | unknown | — | 13,600 | McGill UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT06394297 | VIBE - Virtual Image Guided Brachytherapy Emulation for Locally Advanced Cervical Cancer (LACC)(VIBE) | unknown | N/A | 30 | Fundacao ChampalimaudOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06395064 | The Effect of Dimenhydrinate on Postoperative Nausea and Vomiting After Abdominal Hysterectomy: Randomized-controlled Trial | unknown | N/A | 160 | Preeyaporn JirakittidulOTHER | 0 | May 1, 2024 | clinicaltrials |
| NCT05458544 | [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application(LUCIDA) | unknown | Phase 1 / Phase 2 | 26 | FutureChemINDUSTRY | 1 | Apr 29, 2024 | clinicaltrials |
| NCT05579184 | [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2(LUCIDA_2) | unknown | Phase 2 | 20 | FutureChemINDUSTRY | 1 | Apr 29, 2024 | clinicaltrials |
| NCT06387238 | Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer | unknown | N/A | 150 | Peking University First HospitalOTHER | 0 | Apr 29, 2024 | clinicaltrials |
| NCT00831142 | Characterization of Prostate Cancer With 3T MR | unknown | — | 236 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06385847 | To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer | unknown | Phase 2 | 60 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06305494 | Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors | unknown | — | 425 | Khon Kaen UniversityOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT03558048 | The Effect of IBD Flares on Serum PSA | unknown | — | 400 | Northwestern UniversityOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05989724 | A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors | unknown | Phase 1 | 150 | Qurgen Inc.INDUSTRY | 1 | Apr 24, 2024 | clinicaltrials |
| NCT06253169 | HPV DNA Self-sampling in a General Practitioner's Office.(ASTRA) | unknown | — | 2,000 | Patient Organization VeronicaOTHER_GOV | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06378840 | the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer | unknown | — | 20 | RenJi HospitalOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06376604 | Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies | unknown | N/A | 30 | L-Nutra IncINDUSTRY | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05635344 | A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia | unknown | Phase 2 | 20 | Imperial College LondonOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05657483 | Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study | unknown | — | 128 | University of Campania Luigi VanvitelliOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06366308 | Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population | unknown | — | 10,000 | West China HospitalOTHER | 0 | Apr 16, 2024 | clinicaltrials |
| NCT03700099 | Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide | unknown | Phase 2 | 30 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | unknown | — | 2,700 | Beijing Friendship HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT05748353 | Endocrine Disruptors and Life STILe in Breast Cancer Development(STILVARCA) | unknown | — | 275 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06363708 | Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer | unknown | N/A | 20 | Zhongnan HospitalOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06308406 | A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer | unknown | Phase 1 / Phase 2 | 54 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 11, 2024 | clinicaltrials |
| NCT05848648 | PPK Study Based on Quantitative Pharmacology in Patients With Pamipril | unknown | — | 50 | Qianfoshan HospitalOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06355076 | New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection | unknown | N/A | 94 | Qilu Hospital of Shandong UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT05669443 | Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy | unknown | N/A | 42 | Gangnam Severance HospitalOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT06351228 | Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project(Eternity) | unknown | — | 400 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT02266745 | A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts | unknown | Phase 2 | 109 | Promontory Therapeutics Inc.INDUSTRY | 2 | Apr 5, 2024 | clinicaltrials |
| NCT05123391 | Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer | unknown | N/A | 60 | Pontificia Universidad Catolica de ChileOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT06347614 | Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective Study(Two-step RP) | unknown | — | 30 | Sun Yat-sen UniversityOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT06344715 | Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC. | unknown | Phase 1 | 78 | SL VAXiGENINDUSTRY | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06241235 | Study of ZG005 in Combination With Paclitaxel+Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma | unknown | Phase 1 / Phase 2 | 48 | Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY | 1 | Apr 2, 2024 | clinicaltrials |
| NCT06341855 | Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer | unknown | N/A | 100 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 71 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06103526 | Immunonutrition in ERAS Protocols in Gynecologic Oncology(NUTRIGO) | unknown | N/A | 200 | National and Kapodistrian University of AthensOTHER | 1 | Mar 28, 2024 | clinicaltrials |
| NCT01851018 | Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment(HyBraFi) | unknown | N/A | 30 | CHU de Quebec-Universite LavalOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT05305820 | Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy(PANO) | unknown | N/A | 36 | Dublin City UniversityOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT03795337 | Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-II)(HYPOSTAT-II) | unknown | N/A | 475 | University Hospital Schleswig-HolsteinOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06317948 | Improving the Quality of Radiotherapy by Multi-Institution Knowledge-Based Planning Optimization Models (Acronym: MIKAPOCo, Multi-Institutional Knowledge-based Approach in Plan Optimization for the Community)(MIKAPOCo) | unknown | — | 1,000 | IRCCS Ospedale San RaffaeleOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06320418 | The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression | unknown | — | 56 | Ain Shams UniversityOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06317610 | Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids | unknown | — | 100 | Chongqing University Cancer HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT04903873 | A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 110 | EutilexINDUSTRY | 2 | Mar 15, 2024 | clinicaltrials |
| NCT06242522 | Fertility and Pregnancy After Avelumab Treatment(FERTILAVE) | unknown | N/A | 50 | Hospices Civils de LyonOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06313775 | Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy | unknown | N/A | 18 | Sanpasitthiprasong HospitalOTHER_GOV | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06314113 | Evaluation of Oral EGCG Treatment for L-SIL Associated With HPV Infection(EGCG-HPV) | unknown | — | 50 | University of PalermoOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06304922 | BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary | unknown | — | 45 | Assiut UniversityOTHER | 0 | Mar 12, 2024 | clinicaltrials |
Data updated 22 days agoSource updated May 9, 2024source: clinicaltrials